← Browse by Condition
Medical Condition
colitis ulcerative
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2, Phase 3
NCT06681181 Phase 1
Recruiting
A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy Participants
Enrollment
48 pts
Location
United Kingdom
Sponsor
GlaxoSmithKline
NCT07380022
Recruiting
Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB Defense and Goodphyte Immunity in Adults With Chronic Diseases.
Enrollment
100 pts
Location
Greece
Sponsor
University of Thessaly
NCT05076175 Phase 2, Phase 3
Recruiting
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Enrollment
120 pts
Location
United States, Austr...
Sponsor
Bristol-Myers Squibb
NCT07302360
Recruiting
A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis
Enrollment
200 pts
Location
China
Sponsor
Xian-Janssen Pharmaceutical Lt...